StonvexLoading…
StonvexStonvexStonvexCore line items from QUBT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $682.00K | $373.00K | $358.00K |
Operating Income | $-51.08M | $-25.94M | $-26.24M |
Net Income | $-18.67M | $-68.54M | $-27.02M |
EPS (Diluted) | $-0.11 | $-0.73 | $-0.42 |
Total Assets | $1.62B | $153.56M | $74.36M |
Total Liabilities | $20.66M | $46.27M | $5.65M |
Cash & Equivalents | $737.88M | $78.94M | $2.06M |
Free Cash Flow OCF − CapEx | $-36.98M | $-22.25M | $-20.43M |
Shares Outstanding | 224.16M | 129.01M | 77.45M |